These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21132310)

  • 1. Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on hemodynamics.
    Schillinger W; Hünlich M; Sossalla S; Hermann HP; Hasenfuss G
    Clin Res Cardiol; 2011 May; 100(5):433-8. PubMed ID: 21132310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.
    Fried JA; Nair A; Takeda K; Clerkin K; Topkara VK; Masoumi A; Yuzefpolskaya M; Takayama H; Naka Y; Burkhoff D; Kirtane A; Karmpaliotis D; Moses J; Colombo PC; Garan AR
    J Heart Lung Transplant; 2018 Nov; 37(11):1313-1321. PubMed ID: 29678608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intraaortic balloon pumping on acute myocardial infarction in 64 cases of cardiogenic shock, severe heart failure and mechanical heart failure.
    Ida T; Yamate N; Osaka S; Takei H; Ikeshita M; Shoji T; Tanaka K; Takano T
    Jpn Circ J; 1984 Mar; 48(3):276-87. PubMed ID: 6708297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
    Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
    Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock.
    Pavlidis AN; Redwood SR; Clapp BR
    J Invasive Cardiol; 2014 May; 26(5):E50-1. PubMed ID: 24791724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impedance cardiography for aortic balloon counterpulsation impact assessment on patients hemodynamics during acute myocardial infarction.
    Brazdzionyte J; Macas A
    Medicina (Kaunas); 2006; 42(11):904-13. PubMed ID: 17172792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock.
    Malik FS; Mehra MR; Uber PA; Park MH; Scott RL; Van Meter CH
    J Card Fail; 1999 Mar; 5(1):31-7. PubMed ID: 10194658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intra-aortic balloon pump (IABP) counterpulsation. Do we still need it and if so when?].
    Russ M
    Med Klin Intensivmed Notfmed; 2015 Sep; 110(6):402-6. PubMed ID: 26340798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Hemodynamic Response to Intra-Aortic Balloon Counterpulsation in Patients With Cardiogenic Shock Resulting from Acute Myocardial Infarction Versus Acute Decompensated Heart Failure.
    Malick W; Fried JA; Masoumi A; Nair A; Zuver A; Huang A; Haythe J; Farr M; Rabbani L; Karmpaliotis D; Kirtane AJ; Topkara VK; Takeda K; Garan AR
    Am J Cardiol; 2019 Dec; 124(12):1947-1953. PubMed ID: 31648782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study.
    Hermann HP; Pieske B; Schwarzmüller E; Keul J; Just H; Hasenfuss G
    Lancet; 1999 Apr; 353(9161):1321-3. PubMed ID: 10218531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
    Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
    Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis.
    Liu H; Wu X; Zhao X; Zhu P; Han L
    J Int Med Res; 2016 Jun; 44(3):433-43. PubMed ID: 27020597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-aortic balloon pump in acute chest pain and cardiogenic shock - a long-term follow-up.
    Bendz B; Gude E; Ragnarsson A; Endresen K; Aaberge L; Geiran O; Simonsen S
    Scand Cardiovasc J; 2019 Dec; 53(6):337-341. PubMed ID: 31476881
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical versus pharmacologic support for cardiogenic shock.
    Dhar G; Jolly N
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):626-9. PubMed ID: 20049971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.